ThinkGenetic, Inc., a Lafayette, Louisiana-based maker of an artificial intelligence-driven SymptomMatcher for genetic disorders, closed its $1.5M angel round of funding.
The final $95k investment of five investors was led by entrepreneur and investor, Cian Robinson, Executive Director of the Innovation, Research, and Real Estate Investments division of Lafayette General Health System. Mr. Robinson has been active as a mentor to the company since ThinkGenetic was accepted into the Accelerate South accelerator program in Lafayette, Louisiana, in 2018.
The company intends to use the funds to expand its range of services and personnel, create new partnerships and develop new technology to complement current offerings. In addition, the new relationship with Lafayette General Health System will bring new services to Louisiana including clinical trials and electronic medical record reviews.
Led by CEO Dave Jacob, ThinkGenetic locates individuals with diagnosed and undiagnosed genetic diseases using artificial intelligence (AI) solutions. Its SymptomMatcher makes it easy to find possible explanations for unrelated symptoms and health issues. It uses plain language and a simple question-and-answer format to guide users through the process.